Serum Zinc, Peptic Ulcer Disease and H. Pylori Infection

Sponsor
Ain Shams University (Other)
Overall Status
Completed
CT.gov ID
NCT02716025
Collaborator
(none)
75
22

Study Details

Study Description

Brief Summary

Fifty consecutive patients with symptoms suggestive of peptic ulcer disease were included. All underwent complete clinical evaluation, laboratory investigations, upper gastrointestinal endoscopy and rapid urease test. Measurement of serum zinc level was done for all the included patients in addition to twenty five age and sex matched healthy control subjects.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Upper gastrointestinal endoscopy

Study Design

Study Type:
Observational
Actual Enrollment :
75 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Study Start Date :
Oct 1, 2013
Actual Primary Completion Date :
Aug 1, 2015
Actual Study Completion Date :
Aug 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Case Group

Procedure: Upper gastrointestinal endoscopy
Thorough examination of the esophagus, stomach and duodenum to the second part was done to all patients using Olympus CV-150 or Pentax EPM-3500.

Control Group

Outcome Measures

Primary Outcome Measures

  1. Detection of positive upper GIT endoscopic findings [upon endoscopy]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Symptoms suggestive of peptic ulcer disease like epigastric pain, dyspepsia, heartburn
Exclusion Criteria:
  • Patients who received zinc supplementation, proton pump inhibitors (PPI), non-steroidal anti-inflammatory drugs (NSAIDs)

  • Those presented with hematemesis or melena

  • Those with chronic liver disease, renal failure, malabsorption or previous gastric surgery

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Ain Shams University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sara Abdelhakam, Assistant Professor, Ain Shams University
ClinicalTrials.gov Identifier:
NCT02716025
Other Study ID Numbers:
  • 811
First Posted:
Mar 22, 2016
Last Update Posted:
Mar 22, 2016
Last Verified:
Mar 1, 2016
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 22, 2016